K-134, a phosphodiesterase 3 inhibitor, reduces vascular inflammation and hypoxia, and prevents rupture of experimental abdominal aortic aneurysms

by Naoki Unno, MD, Hiroki Tanaka, MD, PhD, Tatsuro Yata, MD, PhD, Takafumi Kayama, MD, Yuta Yamanaka, MD, Hajime Tsuyuki, MD, Masaki Sano, MD, PhD, Kazunori Inuzuka, MD, PhD, Ena Naruse, CVT, Hiroya Takeuchi, MD, PhD
Published 2020-01-01